Xtx Topco LTD Ginkgo Bioworks Holdings, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.28 - $1.16 $261,491 - $1.08 Million	933,898 New	933,898 $308,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $104,608 - $165,033	64,974 New	64,974 $117,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $191,128 - $412,744	117,257 Added 180.54%	182,205 $307,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $33,625 - $172,275	46,063 Added 243.91%	64,948 $203,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $14,658 - $27,984	6,663 Added 54.52%	18,885 $45,000
Q1 2022 May 13, 2022	SELL	$2.83 - $8.69 $17,353 - $53,287	-6,132 Reduced 33.41%	12,222 $49,000
Q4 2021 Feb 11, 2022	BUY	$8.31 - $14.92 $152,521 - $273,841	18,354 New	18,354 $153,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.